Management Name : Mr PONGTEP THITHAPAND | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 27/06/2018

Management Name : Miss WANNAPA NOODSOR | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 02/08/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 20/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 21/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 22/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 25/06/2018

Of Details DOD BIOTECH PUBLIC COMPANY LIMITED 2021   Company Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021   Consolidated Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Reviewed

been audited by the Company's certified public accountant with details as follows. Total revenues of the Company and subsidiaries in the consolidated financial statements in 2018 were equal to 468.05

Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the

Financial Analysis for Financial Statement and Operating Performance of Year 2023 Revenues from Sales and Services The Company and its Subsidiaries have total income from sales and services equal to 2,329.81